Furthermore, we detected a greater prevalence of RECQL4 high amplification in metastatic lesions compared to primary tumours, but also a predisposition for RECQL4 high amplification (57%) in metastases of multiple tumour entities compared to the diploid status (39%) (Figure 1C, p = 7.11e‐24). Here, RECQL4 is linked to neoplasm.